Compugen Ltd.
CGEN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,891 | $1,257 | $2,284 | $1,471 |
| % Growth | 50.4% | -45% | 55.3% | – |
| Cost of Goods Sold | $1,650 | $1,665 | $2,400 | $675 |
| Gross Profit | $241 | -$408 | -$116 | $796 |
| % Margin | 12.7% | -32.5% | -5.1% | 54.1% |
| R&D Expenses | $5,800 | $5,641 | $5,773 | $5,911 |
| G&A Expenses | $0 | $2,239 | $2,367 | $2,201 |
| SG&A Expenses | $2,334 | $2,380 | $2,506 | $2,368 |
| Sales & Mktg Exp. | $0 | $141 | $139 | $167 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8,134 | $8,021 | $8,279 | $8,279 |
| Operating Income | -$7,893 | -$8,429 | -$8,395 | -$7,483 |
| % Margin | -417.4% | -670.6% | -367.6% | -508.7% |
| Other Income/Exp. Net | $954 | $1,070 | $1,245 | $1,370 |
| Pre-Tax Income | -$6,939 | -$7,359 | -$7,150 | -$6,113 |
| Tax Expense | $40 | -$17 | $31 | $4 |
| Net Income | -$6,979 | -$7,342 | -$7,181 | -$6,117 |
| % Margin | -369.1% | -584.1% | -314.4% | -415.8% |
| EPS | -0.075 | -0.079 | -0.078 | -0.068 |
| % Growth | 5% | -0.9% | -13.9% | – |
| EPS Diluted | -0.075 | -0.079 | -0.078 | -0.068 |
| Weighted Avg Shares Out | 93,539 | 93,527 | 92,308 | 89,539 |
| Weighted Avg Shares Out Dil | 93,539 | 93,527 | 92,308 | 89,539 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,070 | $1,245 | $1,390 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6,939 | -$7,359 | -$8,395 | -$7,483 |
| % Margin | -366.9% | -585.4% | -367.6% | -508.7% |